FDA Clearance Tracker · K243062
BD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD Intelliport Gateway (516232); BD Intelliport Mount (516233); BD Intelliport Charger (516231)
Last checked: Nov 20, 2026Latest source record: Jun 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 20, 2025
Substantially Equivalent
Time to decision
266 days
Received Sep 27, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243062
- Device name
- BD Intelliport System; BD Intelliport Reader (516230); BD Intelliport Sensor (516229); BD Intelliport Gateway (516232); BD Intelliport Mount (516233); BD Intelliport Charger (516231)
- Applicant
- Becton Dickinson
- Applicant location
- Franklin Lakes, NJ
- Received
- Sep 27, 2024
- Decided
- Jun 20, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Infusion Safety Management Software (PHC)
- Device class
- Class II
- Regulation
- 21 CFR 880.5725
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PHC. The earliest in FDA's data is K141193, decided Jul 25, 2014.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243062
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Becton Dickinson
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261379 · Decided Oct 27, 2026 · 183 days after receipt
Device type: Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings (QVF) · Laboratory Medicine & Pathology
K252344 · Decided Oct 16, 2026 · 445 days after receipt
Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA) · Laboratory Medicine & Pathology
K262163 · Decided Sep 14, 2026 · 80 days after receipt
Device type: Culture Media, Antimicrobial Susceptibility Test, Mueller Hinton Agar/Broth (JTZ) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.